PB0127 D-Dimer: Advantage Lost in the Post COVID Era?!

ISTH Academy, Faculty / Presenters, 406730

PB0130 High-throughput 384 Well Microplate Factor Activity Assay

ISTH Academy, Faculty / Presenters, 406731

PB0126 A Novel Flow Cytometric Method for Studying Murine Reticulated Platelets Using SYTO 13 Green

ISTH Academy, Faculty / Presenters, 406732

PB0125 Preoperative Thromboelastometry and Pro-Thrombotic Biomarkers According to Clinical Venothromboembolic (VTE) Risk Assessment in Bariatric Surgery Patients

ISTH Academy, Faculty / Presenters, 406733

PB0122 Circulating Immature Platelet Fraction is Associated with Increased Platelet Activity

ISTH Academy, Faculty / Presenters, 406734

PB0124 Treatment with PCSK9 Inhibitors in Patients with Familial Hypercholesterolemia Lowers Plasma Levels of Platelet Activating Factor and its Precursors: A Combined Metabolomic and Lipidomic Approach

ISTH Academy, Faculty / Presenters, 406735

PB0120 Plasma Profiling of Patients on Vitamin K Antagonists Treatment: A Targeted Quantitative Proteomic Approach

ISTH Academy, Faculty / Presenters, 406736

PB0121 Relationship of Thrombo-Inflammatory Biomarkers with Oxidative Stress Level in Non-Small Cell Lung Cancer Patients

ISTH Academy, Faculty / Presenters, 406737

PB0134 Use case Scenarios for a Portable Near-Patient Hemophilia A Testing Device

ISTH Academy, Faculty / Presenters, 406738

PB0132 Hemostatic Evaluation of Patients with Thrombocytopenia Receiving Platelet Transfusion using the Total Thrombus Formation Analysis System (T-TAS)

ISTH Academy, Faculty / Presenters, 406739

PB0131 Impedance Aggregometry in Elective Coronary Surgery: A Prospective Observational Trial

ISTH Academy, Faculty / Presenters, 406740

PB0135 Expression of an Antifibrinolytic Peptide in Donor Platelets Extends Clot Stability

ISTH Academy, Faculty / Presenters, 406741

PB0141 Characterizing the Transcriptomic Profile of Acquired Hemophilia Using RNA-Seq

ISTH Academy, Faculty / Presenters, 406742

PB0138 COVID-19 Induces miRNA Changes-ACE-2 Related Network: In Silico, Machine Learning and Validation Analysis

ISTH Academy, Faculty / Presenters, 406743

PB0139 Heavy Menstrual Bleeding GWAS Meta-Analysis in >40,000 Cases and >383,000 Controls Reveals 29 Loci Suggesting Multiple Contributing Pathways of Etiology

ISTH Academy, Faculty / Presenters, 406744

PB0137 Diagnostic and Predictive Value of Circulating MicroRNAs and their Regulation of the BDNF Signaling Pathway in Stroke Patients

ISTH Academy, Faculty / Presenters, 406745

PB0136 Excessive Exercise Increases Metabolites Associated with Pathophysiologic Changes in Ultramarathon Runners

ISTH Academy, Faculty / Presenters, 406746

PB1191 Prevalence of Anti-PF4 Antibodies in a Healthy Brazilian Population after Immunization with AstraZeneca Vaccine

ISTH Academy, Faculty / Presenters, 406747

PB1189 Concentrations of Direct Oral Anticoagulants Acting as FXa Inhibitors Could not be Accurately Determined in Patients Treated with Therapeutic Doses of Low Molecular Heparin as Bridging Therapy

ISTH Academy, Faculty / Presenters, 406748

PB1190 Evaluation of Anti-Xa Assay for Monitoring Low Molecular Weight Heparin (LMWH) Using Dedicated Stago Reagent and Analyser

ISTH Academy, Faculty / Presenters, 406749

PB1185 Change in the Pattern of HIT(LIA)-Negative Patients after Immunization with AstraZeneca Vaccine in a Brazilian Population

ISTH Academy, Faculty / Presenters, 406750

PB1186 Combined DOAC and Antiplatelet Therapy Caused Menorrhagia in Young Woman -Case Report

ISTH Academy, Faculty / Presenters, 406751

PB1187 High Plasma Dabigatran Levels Causing Falsely Low Fibrinogen Results: A Report of Two Cases

ISTH Academy, Faculty / Presenters, 406752

PB1188 Use of DOAC-Stop to Guide Warfarin Therapy in Patients Receiving Argatroban

ISTH Academy, Faculty / Presenters, 406753

PB1182 Disparities in the Distribution of Diagnostic Tests on Hemostasis and Thrombosis in Argentina

ISTH Academy, Faculty / Presenters, 406754

PB1184 Monitoring of Low Molecular Weight Heparin by Thrombodynamics Analyser System (TD T2 T) in Intensive Care Patients with COVID-19 Infection

ISTH Academy, Faculty / Presenters, 406755

PB1179 Evaluation of the Point-of-Care H10 Hemcheck Device to Detect Haemolysis in Whole Blood

ISTH Academy, Faculty / Presenters, 406756

PB1180 The Differences and Correlations of LTA Results Obtained Using Different Sampling Methods

ISTH Academy, Faculty / Presenters, 406757

PB1176 Analytical Performances Evaluation of the sthemO VWF:Ag Assay on the sthemO 301 Analyzer

ISTH Academy, Faculty / Presenters, 406758

PB1177 Preliminary Performance Data of an Anti-Xa Assay for the Quantitative Determination of Edoxaban

ISTH Academy, Faculty / Presenters, 406759

PB1178 Presentation of Four Real-Life Patients with Persistently Low Both Peak and Trough Direct Oral Anticoagulant Levels in Plasma: Potential Effect of Drug-Drug Interactions

ISTH Academy, Faculty / Presenters, 406760

PB1172 Antiphospholipid Antibodies in Unselected Consecutive Patients Referred for Testing

ISTH Academy, Faculty / Presenters, 406761

PB1173 Comparison of Rivaroxaban Concentrations Measured by Anti-Xa Rivaroxaban Calibrated Assay and LC-MS/MS

ISTH Academy, Faculty / Presenters, 406762

PB1174 Effect of Haemolysis on Coagulation Tests as Performed on HORIBA Yumizen G1550 Analyser. How HIL Auto-Check Can Help

ISTH Academy, Faculty / Presenters, 406763

PB1175 Resonant Acoustic Rheometry (RAR) for the Characterization of Hemostatic Properties Compared to von Clauss Fibrinogen and TEG 6 s Functional Fibrinogen

ISTH Academy, Faculty / Presenters, 406764

PB1168 Correlations between Concentrations and Anticoagulant Effects are Different among Direct Oral Anticoagulants Administered to Patients

ISTH Academy, Faculty / Presenters, 406765

PB1169 Evaluating the Clinical Utility of Prothrombin Time-Derived Fibrinogen Method

ISTH Academy, Faculty / Presenters, 406766

PB1170 Evaluation of the Analytical Performance of an Automated von Willebrand Factor GPIbM Activity Assay

ISTH Academy, Faculty / Presenters, 406767

PB1155 Analytical Performances Evaluation of the sthemO DDi Assay on the sthemO 301 Analyzer

ISTH Academy, Faculty / Presenters, 406768

PB1156 Clinical Performance Evaluation of the New Stago System for Fibrinogen and Thrombin Time Determination: sthemO Fib and sthemO Thrombin on sthemO 301 Analyzer

ISTH Academy, Faculty / Presenters, 406769

PB1157 Comparison of (Semi-)Automated Thrombin Generation Platforms for Specific Coagulopathies with Bleeding Diathesis

ISTH Academy, Faculty / Presenters, 406770

PB1158 Congenital FVII Deficiency: Analysis of Phenotype and Genotype

ISTH Academy, Faculty / Presenters, 406771

PB1159 Critical Values in Hemostasis Laboratory. Analysis in a 3 Years Period Including Pandemics

ISTH Academy, Faculty / Presenters, 406772

PB1160 Detection of Drug-Induced Platelet Inhibition with Sonic Estimation of Elasticity via Resonance Using the QuantraTM: An Observational invitro Study with Healthy Volunteers

ISTH Academy, Faculty / Presenters, 406773

PB1161 Evaluation of Three Prothrombin Time Reagents and their Sensitivity to Extrinsic Pathway Factor Deficiencies (FII, FV and FVII)

ISTH Academy, Faculty / Presenters, 406774

PB1162 Precision Performances Evaluation of the Routine Hemostasis Tests Panel sthemO PT, sthemO PTT A, sthemO CK Prest, sthemO Fib and sthemO Thrombin on sthemO 301 Analyzer

ISTH Academy, Faculty / Presenters, 406775

PB1163 Rapid, Point-of-Care Detection of Apixaban in Patients Administered Andexanet alfa for Intracranial Hemorrhage

ISTH Academy, Faculty / Presenters, 406776

PB1166 The True Effect of Haemolysis Interference on Routine Coagulation Tests Using Paired Matched Samples Performed on the Sysmex CN-Series Coagulation Analyser

ISTH Academy, Faculty / Presenters, 406777

PB1142 A Rapid Centrifugation 4000 g, 4 min Does not Impact Routine Coagulation Assays

ISTH Academy, Faculty / Presenters, 406778

PB1143 Analytical Performance Evaluation of a New Stago System SthemO 201

ISTH Academy, Faculty / Presenters, 406779

PB1144 Choice of Reference Plasma for Intraassay Thrombin Generation Normalization

ISTH Academy, Faculty / Presenters, 406780

PB1145 Coagulation Assays for Assessing Direct Factor Xa Inhibitor Oral Anticoagulant Reversal Effects

ISTH Academy, Faculty / Presenters, 406781

PB1146 Comparison of Three Warfarin Monitoring Tests (PT, P&P and Fiix test) in Anticoagulated and Non-Anticoagulated Lupus Anticoagulant Positive Plasma Samples

ISTH Academy, Faculty / Presenters, 406782

PB1147 Effect of High-Dose Direct Anticoagulant Drugs and DOAC-Remove on Lupus Anticoagulant Detection by a Hexagonal Phase Phospholipid Assay

ISTH Academy, Faculty / Presenters, 406783

PB1148 Frozen Plasmas Can Replace Fresh Plasmas in ISI Calibrations for Secondary Thromboplastin Standards for Multiple Reagent/ Instrument Combinations

ISTH Academy, Faculty / Presenters, 406784

PB1149 International Normalised Ratio Measurement During Bridging with Low Molecular Weight Heparin

ISTH Academy, Faculty / Presenters, 406785

PB1150 Light Transmission Aggregometry, Comparison of a Semi-Automated Device (APACT 4004) to an Automated One (Atellica® COAG 360)

ISTH Academy, Faculty / Presenters, 406786

PB1151 Performance Evaluation of a Reflexive Algorithm for Suspected Heparin Induced Thrombocytopenia (HIT)

ISTH Academy, Faculty / Presenters, 406787

PB1152 Reporting of DOAC Concentration as FXa Inhibitory Units - Potential Solution for Smaller Laboratories?

ISTH Academy, Faculty / Presenters, 406788

PB1153 Shortening of APTT when Heparin Neutralising Calcium Solution Replaces Calcium Alone is Highly Specific for the Presence of Heparin

ISTH Academy, Faculty / Presenters, 406789

PB1154 Temporary Isolated Reagent-Specific Gross Prolongation of APTT Can be Caused by Acidosis

ISTH Academy, Faculty / Presenters, 406790

PB1139 Establishment of a Novel System based on Clot Waveform Analysis for the Quick Differential Diagnosis of Activated Partial Thromboplastin Time (aPTT)-Prolonged Plasma Samples

ISTH Academy, Faculty / Presenters, 406791

PB1140 Laboratory Features and Genotype of a Family with Heritable Dysfibrinogenaemia (HD)

ISTH Academy, Faculty / Presenters, 406792

PB1141 Modifying Clot-Fibrinolysis Waveform Analysis to Assess Anticoagulant and Antifibrinolytic Activity Exerted by Thrombin in the Presence of Thrombomodulin

ISTH Academy, Faculty / Presenters, 406793

PB1128 A Noble Microfluidic-Thromboelastograph (micro-TEG) Analysis of Whole Blood Coagulation and Fibrinolysis

ISTH Academy, Faculty / Presenters, 406794

PB1129 Analytical Performances Evaluation of the Thrombophilia Hemostasis Test Panel on sthemO 301 Analyzer

ISTH Academy, Faculty / Presenters, 406795

PB1130 Anticoagulant Activity of Factor Xa-Inhibiting DOACs is Increased Synergistically by Dabigatran and Argatroban

ISTH Academy, Faculty / Presenters, 406796

PB1131 Clinical Performance Evaluation of the New Stago System for Prothrombin Time Determination: sthemO PT Assay on sthemO 301 Analyzer

ISTH Academy, Faculty / Presenters, 406797

PB1132 Comparison of Thrombophilia Assay Results for the ISTH/SSC Plasma Standard from Different EQA Providers – Data from the EQATH Group

ISTH Academy, Faculty / Presenters, 406798

PB1133 DaXa, a Non-Calibrated Anti-FXa Assay that can be Used to Quantify DOAC Concentration in Acute Medical Emergencies

ISTH Academy, Faculty / Presenters, 406799

PB1134 Determination and Verification of Reference Intervals on the Automated Coagulation Analyzer sthemO 301

ISTH Academy, Faculty / Presenters, 406800

PB1135 Evaluation of Charcoal Based Direct Oral Anticoagulant (DOAC) Neutralisation in the Laboratory Measurement of Lupus Anticoagulant (LA)

ISTH Academy, Faculty / Presenters, 406801

PB1136 Improving Genetic Testing for Antithrombin Deficiency by Optimizing ACMG/AMP Variant Curation Guidelines for the SERPINC1 Gene

ISTH Academy, Faculty / Presenters, 406802

PB1137 Parallelism in PT-Based One-Stage Extrinsic Factor Assays; is Slope Ratio or %CV a Better Indicator?

ISTH Academy, Faculty / Presenters, 406803

PB1138 The Impact of Switching from Anti-Factor Xa (anti-Xa) Assays to APTT to Monitor Intravenous (IV) Unfractionated Heparin (UFH) at a Quaternary Care Academic Centre

ISTH Academy, Faculty / Presenters, 406804

PB1127 Performance of Different Pairs of APTTs with High and Low Sensitivity to Phospholipids to Diagnose Lupus Anticoagulant

ISTH Academy, Faculty / Presenters, 406805

PB1116 Applications of DOAC Removal in the Laboratory

ISTH Academy, Faculty / Presenters, 406806

PB1117 Congenital Thrombotic Thrombocytopenic Purpura: Identification of Two Heterozygous Mutations in Splice Sites through NGS Sequencing

ISTH Academy, Faculty / Presenters, 406807

PB1118 Construction of a New Model for Estimating Causes of APTT Prolongation Using AI for Clot Waveform Analysis (CWA)

ISTH Academy, Faculty / Presenters, 406808

PB1119 Evaluation of Assay Performance Measuring Plasma Concentrations of Apixaban, Edoxaban, Rivaroxaban Using a Standard Heparin Reagent on a Fully Automated Coagulation Analyser

ISTH Academy, Faculty / Presenters, 406809

PB1121 Laboratory INRs Determined with Commercial Thromboplastins in >450 Centres Before and after the Establishment of the IRP for Human Thromboplastin - rTF 16 : Data from UK NEQAS for Blood Coagulation

ISTH Academy, Faculty / Presenters, 406810

PB1122 Limits on the Correction of Inner Filter Effect and Substrate Consumption by the Calibrated Automated Thrombinography Algorithm: An Edge of Failure Study

ISTH Academy, Faculty / Presenters, 406811

PB1123 Measurement of Activated Factor X Based on Complex Formation with Tissue Factor Pathway Inhibitor

ISTH Academy, Faculty / Presenters, 406812

PB1124 Peak Plasma Concentrations of Apixaban in Children, Adolescents and Young Adults with Different Dosing Regimens Applied

ISTH Academy, Faculty / Presenters, 406813

PB1125 Qualitative and Quantitative Assessment of Direct Oral Anticoagulants (DOACs) in Routine Clinical Practice

ISTH Academy, Faculty / Presenters, 406814

PB1126 The Use of Slope Ratio to Identify the Presence of Inhibitors in One- Stage Intrinsic Clotting Factor Assays on Sysmex CN-Series Analysers

ISTH Academy, Faculty / Presenters, 406815

PB1113 Influence of Clotting Trigger for Functional Protein S Measurement

ISTH Academy, Faculty / Presenters, 406816

PB1114 Method Comparison Analysis of Quantra Relative to Rotational Thromboelastometry and Conventional Coagulation Testing in Cirrhosis

ISTH Academy, Faculty / Presenters, 406817

PB1106 A 2-min 30 sec at 4500g Centrifugation or a 11-min at 2500g are Comparable on 13 Coagulation Assays

ISTH Academy, Faculty / Presenters, 406818

PB1107 AI Classification Model to Discriminate Causes of Prolonged Clotting Time through the Application of Machine Learning to Clot Waveform Analysis Parameters

ISTH Academy, Faculty / Presenters, 406819

PB1108 Correlation of Two Low Molecular Weight Heparin Anti-Xa Assays with Apixaban and Rivaroxaban Calibrated Assays

ISTH Academy, Faculty / Presenters, 406820

PB1109 Development and Evaluation of an Aptamer-Based Affinity Purification Method for Activated Protein C (APC)

ISTH Academy, Faculty / Presenters, 406821

PB1110 Implementation of International Society on Thrombosis and Haemostasis Definitions of Major and Clinically Relevant Non-Major Bleed Events in Electronic Health Records

ISTH Academy, Faculty / Presenters, 406822

PB1111 Lupus Anticoagulant Diagnosis: Real Life Rate of Interferences Due to Anticoagulant Treatment in a Laboratory of a High Complexity Hospital

ISTH Academy, Faculty / Presenters, 406823

PB1112 UK National External Quality Assessment Scheme for Blood Coagulation (UK NEQAS BC) Emicizumab Programme, Survey July 2022 Results for Modified One-Stage Assay and Chromogenic Assay

ISTH Academy, Faculty / Presenters, 406824

PB1103 Clinical Performance Evaluation of the New Stago Systems for APTT Determination: sthemO PTTA and sthemO CK Prest on sthemO 301 Analyzer

ISTH Academy, Faculty / Presenters, 406825

PB1104 Evaluation of Abnormal Routine Coagulation Results (PT and APTT) for Specialist Review in a Tertiary Teaching Hospital

ISTH Academy, Faculty / Presenters, 406826

PB1105 Post-Infusion Monitoring of Afstyla FVIII Replacement Therapy - Data from the UK National External Quality Assessment for Blood Coagulation (UK NEQAS BC) Programme 2022

ISTH Academy, Faculty / Presenters, 406827

PB1205 In Vitro Analysis of Plasma Clots with 0.7 to 10.4 g/L Fibrinogen Concentration by Turbidity, Permeation and Laser Scanning Electron Microscopy

ISTH Academy, Faculty / Presenters, 406828

PB1204 Synergistic Role in Accelerating Clot Formation and Fibrin Polymerisation of Cancer Cells and Platelets: a Thromboelastometric Study

ISTH Academy, Faculty / Presenters, 406829